Napo Pharmaceuticals Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$3.3M
Doctors Paid
1,946
Transactions
8,934
2024 Total
$704,624
Payment Breakdown by Category
Research$2.3M (70.3%)
Consulting$326,577 (9.8%)
Food & Beverage$160,044 (4.8%)
Travel$39,967 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.3M | 346 | 70.3% |
| Consulting Fee | $326,577 | 102 | 9.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $264,932 | 1,763 | 8.0% |
| Food and Beverage | $160,044 | 6,539 | 4.8% |
| Honoraria | $131,675 | 80 | 4.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $62,174 | 22 | 1.9% |
| Travel and Lodging | $39,967 | 82 | 1.2% |
Payments by Type
Research
$2.3M
346 transactions
General
$985,369
8,588 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Phase 3 Multicenter, Randomized, Double Blind Placebo-Controlled Trial Evaluating Crofelemer for the Prophylaxis of Diarrhea in Adult Patients with Solid Tumors Receiving Targeted-Cancer Therapies with or without Standar Chemotherapy | $2.0M | 0 | 259 |
| ON TARGET: A Phase 3 multicenter, randomized, double-blind placebo-controlled trial evaluating crofelemer for the prophylaxis of diarrhea in adult patients with solid tumors receiving targeted-cancer therapies with or without standard chemotherapy regimens | $178,994 | 0 | 50 |
| One Patient IND | $83,298 | 0 | 10 |
| A Phase 4 Open Label Study to Assess the Safety and Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in People Living with HIV/AIDS (PLWHA) with Non-Infectious Diarrhea | $57,412 | 0 | 22 |
| Yield of Diagnostic Tests and Management of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients: A Pilot Study | $22,061 | 0 | 3 |
| A randomized, double-blind, placebo-controlled, parallel group, multicenter study is designed to evaluate the efficacy and safety of orally administered crofelemer in patients with functional diarrhea. | $22,061 | 0 | 2 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Elie Schochet, M.d, M.D | Surgery | Ft Lauderdale, FL | $67,104 | $0 |
| Dr. Robin Beach, Fnp, FNP | Family | Bellaire, TX | $57,645 | $0 |
| Dr. Eric Roeland, Md, MD | Hospice and Palliative Medicine | Portland, OR | $56,852 | $0 |
| Lee Schwartzberg, Md, MD | Hematology | Reno, NV | $52,772 | $0 |
| Dr. Hope Rugo, Md, MD | Internal Medicine | San Francisco, CA | $51,000 | $0 |
| Pablo Okhuysen, M.d, M.D | Infectious Disease | Houston, TX | $48,303 | $0 |
| Dr. David Asmuth, M.d, M.D | Infectious Disease | Sacramento, CA | $45,254 | $0 |
| Corey Siegel, M.d, M.D | Gastroenterology | Lebanon, NH | $43,562 | $0 |
| Dr. Sue Rhee, M.d, M.D | Pediatrics | San Francisco, CA | $39,000 | $0 |
| Sandra Swain, M.d, M.D | Hematology & Oncology | Bethesda, MD | $33,410 | $0 |
| Andrew Mulberg, M.d, M.D | Pediatrics | Camden, NJ | $32,813 | $0 |
| Edward Brettholz, Md, MD | Gastroenterology | New York, NY | $32,478 | $0 |
| Dr. Noah Lee, D.o, D.O | Family Medicine | Oakland Park, FL | $30,168 | $0 |
| Brian Beesley, Do, DO | Family Medicine | Columbus, OH | $17,325 | $0 |
| Dr. Alireza Farabi, Md, MD | Infectious Disease | Las Vegas, NV | $12,370 | $0 |
| Dr. Gary Blick, Md, MD | Internal Medicine | Norwalk, CT | $11,213 | $0 |
| Laveeza Bhatti, Md, MD | Infectious Disease | Beverly Hills, CA | $10,808 | $0 |
| Dr. Mark Scheperle, M.d, M.D | Internal Medicine | Saint Louis, MO | $9,839 | $0 |
| Dr. Mark Tanner, Md, MD | Family Medicine | Atlanta, GA | $8,780 | $0 |
| Dr. David Prelutsky, Md, MD | Internal Medicine | Saint Louis, MO | $8,625 | $0 |
| Douglas Cunningham, D.o, D.O | Geriatric Medicine | Phoenix, AZ | $8,212 | $0 |
| Dr. Douglas Ward, M.d, M.D | Internal Medicine | Washington, DC | $7,720 | $0 |
| Dr. Ronald Grossman, Md, MD | Internal Medicine | New York, NY | $7,520 | $0 |
| Margaret White, Fnp-Bc, FNP-BC | Family | Houston, TX | $6,967 | $0 |
| Mr. Joel Thompson, Pa-C, PA-C | Medical | Charlotte, NC | $6,788 | $0 |
About Napo Pharmaceuticals Inc
Napo Pharmaceuticals Inc has made $3.3M in payments to 1,946 healthcare providers, recorded across 8,934 transactions in the CMS Open Payments database. In 2024, the company paid $704,624. The top product by payment volume is Mytesi ($1.1M).
Payments were distributed across 79 medical specialties. The top specialty by payment amount is Infectious Disease ($177,692 to 327 doctors).
Payment categories include: Food & Beverage ($160,044), Consulting ($326,577), Research ($2.3M), Travel & Lodging ($39,967).
Napo Pharmaceuticals Inc is associated with 1 products in the CMS Open Payments database.